Role evidence
Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 14
Treatment-assignment count: 0
Stratification count: 0
Cdx Established Context
PD-L1 expression
gastric cancer · Combination Therapy
PD-L1 expression is flagged as cdx established context because public trials show inclusion required evidence in 19 contexts. FDA CDx context exists.
Threshold snippets
Fragmentation view
Threshold count: 15
Common snippets: dMMR | MSI-H | MSI-H
Threshold label: Moderate
FDA CDx context
Mapping summary
CDx label: Fda Cdx Context Exists
CDx maturity score: 5/5
Confidence: High
Patent-density signal
Diagnostic appendix
Signal count: 1
Recent signals: 1
Density label: Low
Source links
Evidence paths
https://clinicaltrials.gov/study/NCT03777657 | https://clinicaltrials.gov/study/NCT05233436 | https://clinicaltrials.gov/study/NCT05458219 | https://clinicaltrials.gov/study/NCT04933227 | https://clinicaltrials.gov/study/NCT07385703 | https://clinicaltrials.gov/study/NCT07658872 | https://clinicaltrials.gov/study/NCT06829797 | https://clinicaltrials.gov/study/NCT05329766 | https://clinicaltrials.gov/study/NCT05769725 | https://clinicaltrials.gov/study/NCT04603040 | https://clinicaltrials.gov/study/NCT07266025 | https://clinicaltrials.gov/study/NCT04152889 | https://clinicaltrials.gov/study/NCT07692204 | https://clinicaltrials.gov/study/NCT06250036 | https://clinicaltrials.gov/study/NCT05002686 | https://clinicaltrials.gov/study/NCT05713838 | https://clinicaltrials.gov/study/NCT06587425 | https://clinicaltrials.gov/study/NCT06038396 | https://clinicaltrials.gov/study/NCT06321913